Navigation Links
Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Date:1/6/2009

how AHCC works by impacting specific immune system cells. More studies will be conducted to further investigate the effects of AHCC," said Naoyoshi Terakawa, M.D., Department of Surgery, Kansai Medical University.

In addition to this study, research completed at other institutions with AHCC has shown that it activates important immune white blood cells including macrophages, Natural Killer (NK) cells and Lymphokine-Activated Killer (LAK) cells. AHCC also induces the production of cytokines that serve as chemical messengers between cells. AHCC has been the subject of over 80 research studies worldwide including studies completed at Harvard University's Faulkner Hospital, Yale University and Columbia University Medical Center.

What is AHCC (Active Hexose Correlated Compound)?

AHCC is derived from the hybridization of several subspecies of medicinal mushroom, cultivated in Japan and then produced from a unique manufacturing process. AHCC is the leading immune-enhancing supplement in Japan and is utilized by over 700 hospitals and healthcare facilities worldwide as a standard preventative supplement for incoming patients to help reduce the risk of hospital infections as well as supporting the body's fight against the formation of abnormal cells.*

AHCC is manufactured by Amino Up Chemical Company in Sapporo, Japan and is distributed in the United States by Maypro Industries. Maypro sells AHCC to a number of leading supplement companies including Quality of Life Laboratories, a subsidiary of Maypro.

The AHCC Research Association was founded in 1986 to promote further study. Each year since 1994, over 300 medical doctors and researchers have gathered in Sapporo, Japan for the AHCC Research Association Symposium to share and discuss the latest developments.

To learn more about AHCC, visit the AHCC Research Association Web site at

SOURCE AHCC Research Association
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013  Actavis, Inc. (NYSE: ACT ) ... the U.S. Securities and Exchange Commission (SEC) a registration statement ... Warner Chilcott plc (NASDAQ: WCRX ), ... Warner Chilcott (the "Form S-4"). As previously ... have entered into a definitive agreement pursuant to which ...
(Date:6/18/2013)... CHAPEL HILL, N.C. , June 18, 2013 /PRNewswire/ ... and more difficult for Medical Education groups at large ... practitioners on the safe and effective use of their ... within the pharma industry, it is crucial that these ... of reaching healthcare professionals. To address the ...
(Date:6/18/2013)... SAN LEANDRO, Calif. , June 18, 2013 /PRNewswire/ ... world.  According to the American Association of Ophthalmology, aging ... cataracts, a clouding of the eye,s natural lens. 22 ... by 2020, as Baby Boomers continue to age, that ... moving, high tech world of iPhones, iPads, smart-phones and ...
Breaking Medicine Technology:Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3
... 14 The Fifth Annual Orthopedic Design & Technology (ODT) Conference & Exhibition ... Center, Fort Wayne, Ind. , ... global event brings together orthopedic finished good manufacturers, suppliers and surgeons for networking, general ... , , ...
... 14 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has retained ... England to manage its planned Phase IIb clinical trial in the ... treatment of primary multiple sclerosis-related fatigue (PMSF). , ... In an earlier Phase IIa study, MCT-125 was tested ...
Cached Medicine Technology:Fifth Annual Orthopedic Design & Technology Conference & Exhibition Set for September 22-23 2Fifth Annual Orthopedic Design & Technology Conference & Exhibition Set for September 22-23 3MultiCell Hires Clinical Research Organization to Manage MCT-125 Phase IIb Clinical Trial 2MultiCell Hires Clinical Research Organization to Manage MCT-125 Phase IIb Clinical Trial 3MultiCell Hires Clinical Research Organization to Manage MCT-125 Phase IIb Clinical Trial 4
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s ... Compressor Saver kit at an exceptional price. The 5-2-1 Compressor ... air conditioning unit during start up, saving wear and tear ... unit burn out. , The 5-2-1 Compressor Saver ... uses less power to start and drastically reduces the rush ...
(Date:6/19/2013)... 19, 2013 Kansas City will host its first ... Street Day . A section of Main Street in the midtown ... afternoon of the event. The Main Street Corridor Development ... will help Kansas City join the ranks of dozens of cities ... tool to foster community vibrancy and active lifestyles. , “Ciclovia is ...
(Date:6/19/2013)... June 19, 2013 In 2011, the ... EUR 710 million. Generic drugs form the largest sector, ... value. The pharmaceutical industry is a significant contributor to ... the country’s GDP. Approximately 50% of the total domestic ... pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key ...
(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical ... the publication of the National Osteoporosis Guideline Group ... osteoporosis in postmenopausal women and older men in ... 2009 in Maturitas , the original guidelines ... timely with an additional focus on the management ...
(Date:6/19/2013)... Next Thursday, June 27, 2013, ... organization, and Muzzy Lane Software , a ... the Games for Health community to their interactive ... toward students in grades 4-7 and designed to ... positive choices. The game is part of a ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5
... Fla. and COLUMBUS, Ohio, May 20 Axium ... specialty pharmacy providers, and Definitive Homecare Solutions, the ... of CPR+ as its specialty pharmacy management software ... continued growth, we needed a software platform to ...
... The Technical Board of,Appeal of the European Patent Office ... two competitors against an earlier decision to maintain the,European ... http://www.newscom.com/cgi-bin/prnh/20090520/347917-a ) , ... Introduced in 1999, the VisionBlue product is protected ...
... managed by a specialty pharmacy program were more compliant ... hospitalized for their disease than those who were not ... study completed by HealthCore, Inc. , HealthCore researcher Jingbo ... of Pharmacoeconomic and Outcomes Research 14th Annual International Meeting ...
... RECORDING OF DAVID COOK,S ,IDOL, PERFORMANCE WILL BE SOLD ... Sale of Live Version of ,Permanent, Will Be Donated ... Exactly one year after winning the seventh season ... popular television series in America on Wednesday night to ...
... To commemorate the 80th anniversary of The Children,s ... in Midtown Detroit, a Power of Possibilities Breakfast is ... Book Cadillac.(Logo: http://www.newscom.com/cgi-bin/prnh/20090423/CCWCLOGO ) ... on the ideologies of founder Senator James Couzens. ...
... Ill., May 20 Viant, Inc., a leader in ... they have signed an agreement with Tempe, AZ-based HMA, ... the state of Arizona. Viant customers utilizing the Beech ... access to HMA, Inc.,s Arizona provider networks, which include, ...
Cached Medicine News:Health News:Axium Healthcare Picks CPR+ as Its Specialty Pharmacy Management Software 2Health News:Axium Healthcare Picks CPR+ as Its Specialty Pharmacy Management Software 3Health News:Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force 2Health News:Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force 3Health News:MS patients more compliant with medications when managed by specialty pharmacy 2Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:80th Anniversary Power of Possibilities Breakfast Honors the Children's Center of Wayne County 2Health News:Viant Expands Relationship With HMA for Improved Healthcare Access in AZ 2
... is a small, quiet, high-speed centrifuge. It ... system which results in nearly vibration- free ... both top speed and full breaking in ... changed with a simple push-on/ pull-off; transforming ...
The StatSpin Express 3 provides faster turnaround time and greater productivity for your laboratory....
... Used to establish temporary internal drainage ... following renal transplant. Non-radiopaque ink bands serve ... physician can anticipate where the coil(s) will ... sterile in peel-open packages. Intended for one-time ...
Used for drainage and retrograde pyelogram in pediatric patients. A stiffening stylet is included to aid in catheter placement. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: